Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

被引:0
|
作者
Leitner, H.
机构
来源
JOURNAL FUR KARDIOLOGIE | 2016年 / 23卷 / 1-2期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:54 / 54
页数:1
相关论文
共 50 条
  • [31] In type 2 diabetes with CVD and kidney disease, empagliflozin reduced mortality and hospitalization
    Moist, Louise
    [J]. ANNALS OF INTERNAL MEDICINE, 2018, 168 (10) : JC52 - JC52
  • [32] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Cohen, Scott
    Beckey, Cherylyn
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18): : 1797 - 1797
  • [33] Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
    Singh, Sonal
    Furberg, Curt D.
    [J]. HEART, 2009, 95 (01) : 1 - 3
  • [34] Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
    Wiviott, S. D.
    Raz, I.
    Bonaca, M. P.
    Mosenzon, O.
    Kato, E. T.
    Cahn, A.
    Silverman, M. G.
    Zelniker, T. A.
    Kuder, J. F.
    Murphy, S. A.
    Bhatt, D. L.
    Leiter, L. A.
    McGuire, D. K.
    Wilding, J. P. H.
    Ruff, C. T.
    Gause-Nilsson, I. A. M.
    Fredriksson, M.
    Johansson, P. A.
    Langkilde, A-M.
    Sabatine, M. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 347 - 357
  • [35] Canagliflozin and cardiovascular outcomes in Type 2 diabetes
    Sarraju, Ashish
    Spencer-Bonilla, Gabriela
    Rodriguez, Fatima
    Mahaffey, Kenneth W.
    [J]. FUTURE CARDIOLOGY, 2020, 17 (01) : 39 - 48
  • [36] Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
    Grant, P. J.
    [J]. HEART, 2009, 95 (04) : 332 - 332
  • [37] Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
    Cannon, Christopher P.
    Pratley, Richard
    Dagogo-Jack, Samuel
    Mancuso, James
    Huyck, Susan
    Masiukiewicz, Urszula
    Charbonnel, Bernard
    Frederich, Robert
    Gallo, Silvina
    Cosentino, Francesco
    Shih, Weichung J.
    Gantz, Ira
    Terra, Steven G.
    Cherney, David Z. I.
    McGuire, Darren K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1425 - 1435
  • [38] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Marso, Steven P.
    Daniels, Gilbert H.
    Brown-Frandsen, Kirstine
    Kristensen, Peter
    Mann, Johannes F. E.
    Nauck, Michael A.
    Nissen, Steven E.
    Pocock, Stuart
    Poulter, Neil R.
    Ravn, Lasse S.
    Steinberg, William M.
    Stockner, Mette
    Zinman, Bernard
    Bergenstal, Richard M.
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 311 - 322
  • [39] Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes
    Kumar, Hari K. V. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2478 - 2478
  • [40] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Thwe Htay
    Kyaw Soe
    Arianna Lopez-Perez
    Amy HoangAnh Doan
    Michael A. Romagosa
    KoKo Aung
    [J]. Current Cardiology Reports, 2019, 21